Karyopharm Therapeutics Inc.
KPTI
$4.64
-$0.06-1.28%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.46M | -30.78M | -32.07M | 23.79M | -37.36M |
| Total Depreciation and Amortization | 78.00K | 81.00K | 83.00K | 91.00K | 85.00K |
| Total Amortization of Deferred Charges | 2.57M | 2.36M | 2.41M | 1.40M | 208.00K |
| Total Other Non-Cash Items | -16.65M | -6.88M | -350.00K | -54.30M | 4.06M |
| Change in Net Operating Assets | -1.53M | 9.41M | 10.48M | -9.47M | -10.72M |
| Cash from Operations | -38.98M | -25.81M | -19.45M | -38.50M | -43.73M |
| Capital Expenditure | -- | 53.00K | 0.00 | 0.00 | -195.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.29M | 14.74M | 7.47M | 51.26M | 22.14M |
| Cash from Investing | 15.29M | 14.80M | 7.47M | 51.26M | 21.94M |
| Total Debt Issued | -- | 0.00 | 83.30M | -- | -- |
| Total Debt Repaid | -- | 0.00 | -40.52M | -- | -- |
| Issuance of Common Stock | -- | 680.00K | 0.00 | 772.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -42.78M | 40.19M | -- |
| Cash from Financing | -- | 680.00K | 0.00 | 40.97M | -- |
| Foreign Exchange rate Adjustments | 5.00K | -20.00K | 36.00K | -11.00K | -16.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.69M | -10.35M | -11.94M | 53.72M | -21.80M |